CVR number 43746642
Industry 86.2200 Specialist medical practice activities

KardEndo ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Bankruptcy risk for industry  0.7% 0.7% 0.7% 0.7% 0.7%  
Bankruptcy risk  0.0% 0.0% 0.0% 0.0% 10.2%  
Credit score (0-100)  0 0 0 0 23  
Credit rating  N/A N/A N/A N/A BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 0.0 117  
EBITDA  0.0 0.0 0.0 0.0 115  
EBIT  0.0 0.0 0.0 0.0 115  
Pre-tax profit (PTP)  0.0 0.0 0.0 0.0 114.6  
Net earnings  0.0 0.0 0.0 0.0 89.4  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 0.0 115  
 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 0.0 129  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 0.0 233  
Net Debt  0.0 0.0 0.0 0.0 -233  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 0.0 117  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 0 233  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 0.0%  
Added value  0.0 0.0 0.0 0.0 114.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 0.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 0.0% 97.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 0.0% 49.2%  
ROI %  0.0% 0.0% 0.0% 0.0% 88.6%  
ROE %  0.0% 0.0% 0.0% 0.0% 69.1%  

Solidity 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Equity ratio %  0.0% 0.0% 0.0% 0.0% 55.6%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% 0.0% -203.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Quick Ratio  0.0 0.0 0.0 0.0 2.3  
Current Ratio  0.0 0.0 0.0 0.0 2.3  
Cash and cash equivalent  0.0 0.0 0.0 0.0 232.8  

Capital use efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 0.0 129.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
N/A
2022
N/A
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0